What are the recommended guidelines for evaluating and managing cough in pregnancy?

Management of Cough in Pregnancy

For pregnant women with cough, the evaluation and management approach follows the same systematic algorithm as non-pregnant patients—classifying cough by duration (acute <3 weeks, subacute 3-8 weeks, chronic >8 weeks) and treating the most common causes sequentially—but with critical modifications to avoid teratogenic medications and recognize pregnancy-specific etiologies.

Initial Assessment and Red Flags

Begin by excluding life-threatening conditions and pregnancy-specific complications:

• Obtain chest radiography immediately if hemoptysis, fever >4 days, focal chest signs (crackles, diminished breath sounds), dyspnea, or tachypnea are present, as these suggest pneumonia or pulmonary embolism 1.
• Consider pertussis when cough lasts ≥2 weeks with paroxysms, post-tussive vomiting, or inspiratory whooping sound; obtain nasopharyngeal swab and start empiric macrolide therapy (azithromycin preferred) without awaiting results 1, 2.
• Evaluate for tuberculosis in high-risk patients (immigrant from endemic area, known TB contact, immunosuppression) using chest radiography, sputum AFB, and IGRA testing—delayed diagnosis can be fatal to mother and fetus 3.
• Assess for gastroesophageal reflux disease (GERD), which accounts for 77% of cough in pregnant women without bronchial pathology due to increased intra-abdominal pressure and progesterone-mediated lower esophageal sphincter relaxation 4.

Classification by Duration

Acute Cough (<3 weeks)

Most acute cough in pregnancy is viral upper respiratory infection and requires only supportive care:

• Reassure the patient that symptoms typically peak in the first few days and resolve within 1-2 weeks without antibiotics 5.
• Recommend guaifenesin 200-400 mg every 4 hours (maximum 6 doses daily) to thin secretions; this is FDA-approved and safe in pregnancy 6, 5.
• Suggest non-pharmacologic measures: honey with lemon, adequate hydration, warm facial compresses, steam inhalation, and sleeping with head elevated 6, 5.
• Prescribe short-acting oral decongestants (phenylpropanolamine + chlorpheniramine) for up to 3-5 days only to avoid rebound congestion 5.
• Avoid antibiotics unless bacterial pneumonia is confirmed radiographically, as they provide no benefit for viral infections and increase resistance 1, 6.

Subacute Cough (3-8 weeks)

Subacute cough is most commonly postinfectious, but pregnancy-specific causes must be considered:

• Diagnose postinfectious cough when cough persists 3-8 weeks after acute respiratory infection with non-purulent sputum, no fever, clear lungs except transient wheezes, and no crackles 1, 6.
• Prescribe inhaled ipratropium bromide 2-3 puffs (17-34 mcg per puff) four times daily as first-line therapy; this has the strongest evidence for attenuating postinfectious cough with response expected within 1-2 weeks 1, 6, 5.
• Add inhaled corticosteroids (fluticasone 220 mcg or budesonide 360 mcg twice daily) if cough persists despite ipratropium and adversely affects quality of life; allow up to 8 weeks for full response 1, 6.
• Reserve oral prednisone 30-40 mg daily for 5-10 days only for severe paroxysms that significantly impair quality of life, and only after ruling out upper airway cough syndrome (UACS), asthma, and GERD 1, 6.
• Evaluate for GERD empirically with high-dose proton pump inhibitor therapy (omeprazole 40 mg twice daily) plus dietary modifications, as silent GERD is extremely common in pregnancy and may require 2 weeks to several months for response 6, 4.

Chronic Cough (>8 weeks)

When cough persists beyond 8 weeks, systematically evaluate and treat the three most common causes in sequential and additive fashion:

1. Upper Airway Cough Syndrome (UACS)

• Start first-generation antihistamine-decongestant combination (brompheniramine/pseudoephedrine or chlorpheniramine/phenylephrine) plus intranasal corticosteroid spray (fluticasone or mometasone); improvement typically occurs within days to 1-2 weeks 1, 6.
• Look for "silent" UACS: frequent throat clearing, post-nasal drip sensation, nasal congestion, cobblestoning of posterior pharynx, or pale boggy turbinates on exam 6.

2. Asthma (Including Cough-Variant Asthma)

• Recognize that asthma accounts for 12-24% of chronic cough in pregnancy and may present with cough as the sole manifestation without wheezing or dyspnea 1, 4, 7.
• Perform spirometry with bronchodilator response to identify reversible airway obstruction; if normal but clinical suspicion remains, consider bronchoprovocation challenge 6.
• Initiate or optimize inhaled corticosteroids (fluticasone or budesonide) plus long-acting beta-agonists (salmeterol); complete resolution may require up to 8 weeks 6, 7.
• Continue asthma controller medications throughout pregnancy, as uncontrolled asthma poses greater risk to mother and fetus than medication exposure (gestational hypertension, eclampsia, fetal hypoxemia, perinatal death) 7.

3. Gastroesophageal Reflux Disease (GERD)

• Initiate high-dose PPI therapy (omeprazole 40 mg twice daily) with dietary modifications (avoid large meals, fatty foods, caffeine, chocolate; elevate head of bed; avoid eating within 3 hours of bedtime) 6.
• Allow 2 weeks to several months for response, as GERD-related cough may be slow to resolve 6.
• Recognize that 77% of pregnant women with chronic cough have GERD as the primary etiology, often without typical GI symptoms 4.

Pregnancy-Specific Considerations

Several factors unique to pregnancy require special attention:

• Physiologic changes in pregnancy (increased minute ventilation, decreased functional residual capacity, elevated diaphragm, increased intra-abdominal pressure) increase susceptibility to respiratory complications and GERD 8.
• Respiratory infections carry higher morbidity and mortality in pregnancy due to these physiologic adaptations, requiring higher level of surveillance and lower threshold for intervention 8.
• Avoid ACE inhibitors (teratogenic) if hypertension requires treatment; cough from ACE inhibitors typically resolves within 1-4 weeks of discontinuation 1.
• Avoid codeine and dextromethorphan in the first trimester due to limited safety data; if antitussive is required later in pregnancy, dextromethorphan 60 mg is preferred over codeine 1, 6.

Diagnostic Testing in Pregnancy

Chest radiography is safe and indicated when clinically necessary:

• Do not delay chest X-ray when pneumonia, tuberculosis, or pulmonary embolism is suspected; fetal radiation exposure from a single chest X-ray (0.0005-0.01 mGy) is far below the threshold for harm (50 mGy) 3.
• Order sputum AFB and IGRA testing liberally in pregnant women with persistent cough and risk factors for tuberculosis, as delayed diagnosis can be catastrophic 3.
• Perform spirometry to evaluate for asthma or COPD when chronic cough persists despite empiric therapy 1, 6.

Medications to Avoid in Pregnancy

The following agents are contraindicated or should be avoided:

• Antibiotics for non-bacterial postinfectious cough provide no benefit and increase resistance 1, 6.
• ACE inhibitors are teratogenic and contraindicated throughout pregnancy 1.
• Systemic corticosteroids in high doses or prolonged duration should be minimized; short courses (5-10 days) of prednisone 30-40 mg daily are acceptable when clearly indicated 1, 6.

Follow-Up and Reassessment

Establish clear timelines for expected response and re-evaluation:

• Arrange follow-up within 3-5 days if symptoms worsen or new red flags develop (fever, hemoptysis, dyspnea) 6, 5.
• Schedule clinic or telephone follow-up at 4-6 weeks after initial evaluation to assess response to therapy 1.
• Reclassify as chronic cough and initiate systematic evaluation if cough persists beyond 8 weeks despite appropriate treatment of postinfectious cough 1, 6.
• Consider high-resolution CT chest and bronchoscopy if all empiric therapies fail after 8 weeks and chest X-ray is normal, to evaluate for bronchiectasis, interstitial lung disease, or occult endobronchial lesions 1, 6.

Common Pitfalls to Avoid

• Failing to recognize GERD as the dominant cause of chronic cough in pregnancy (77% of cases) and not initiating empiric PPI therapy 4.
• Withholding chest radiography due to unfounded radiation concerns, leading to delayed diagnosis of pneumonia or tuberculosis 3.
• Prescribing antibiotics for viral postinfectious cough, which provides no benefit and contributes to resistance 1, 6, 5.
• Discontinuing asthma controller medications during pregnancy due to safety concerns, when uncontrolled asthma poses far greater risk to mother and fetus 7.
• Delaying pertussis treatment while awaiting laboratory confirmation; start empiric azithromycin immediately when clinical suspicion is present 1, 2.
• Failing to isolate patients with confirmed or suspected pertussis for 5 days from start of antibiotic treatment 1, 2.